Algernon Pharmaceuticals Inc (AGNPF)

[shell3]

Dear Sirs/Mesdames:

Re: Algernon Pharmaceuticals Inc. (the "Company")

Pursuant to Policy 9 – Name Change, Stock Splits and Share Consolidation of the Canadian Securities Exchange, and further to the Company’s Notice dated February 28, 2023, the Company confirms that it has completed the 4 for 1 stock split effective March 6, 2023, and has mailed out the DRS statements and made available the additional share certificates to the shareholders of the Company on March 13, 2023.
The new issued and outstanding common shares of the Company is 9,653,656. Sincerely,
“Christopher Moreau” Christopher Moreau Chief Executive Officer

https://webfiles.thecse.com/1._Algernon_-_Confirmation_of_Mailing_to_CSE_re_Forward_share_split_-_March_2023.pdf?TZVYRIuUBa63F7r3DFb1gPR1PNTxkEsg